NALOXONE AVAILABILITY - Early Day Motions

House of Commons

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Tabled 30 October 2014
2014-15 Session

That this House notes that there were 765 deaths involving heroin or morphine in 2013, a sharp rise of 32 per cent from 579 deaths in 2012; further notes that many of these fatalities could have been prevented by the use of naloxone as an intervention; recognises that naloxone is a safe and effective medicine which can reverse the effects of opioid overdoses; recalls that in May 2012 the Advisory Council on the Misuse of Drugs (ACMD) recommended that naloxone should be made more widely available; is concerned that regulations to give effect to the ACMD recommendations in England are not planned to be implemented until October 2015; further notes that in Scotland and Wales successful pilots have resulted in national programmes to make naloxone widely available but there has been no such development in England; and calls on the Government to prioritise the roll-out of naloxone across the whole of the UK.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.